Project Grant K08AI193077
- The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $147,486 Project Grant to Trustees of Dartmouth College to study how the hypoxia morphology of Aspergillus fumigatus (a common fungal pathogen) impacts diagnostic methods for invasive pulmonary aspergillosis (IPA). The key objectives are to 1) investigate how the hypoxia-induced gene HrmA regulates the production of antigenic polysaccharides,...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $212,169 Project Grant under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) to The Johns Hopkins University to advance mentorship at the Johns Hopkins Integrated Center for Combating Antimicrobial Resistant Bacteria. The project summary indicates the principal investigator has conducted pivotal research on antimicrobial resistant infections, leading to clinical guidelines, and has...
- This Project Grant award, valued at $200,340.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855). The grant will support the career development of Dr. Brittany L Morgan Bustamante, an infectious disease epidemiologist at the University of California, Berkeley, as she seeks to become an independent researcher studying the upstream and contextual factors shaping the risk and...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $186,451 Project Grant under the Allergy and Infectious Diseases Research (CFDA 93.855) program to the University of Maryland, College Park. The grant is for a project titled "A Murine Model for HIV/AIDS Associated Cryptococcal IRIS: Characterizing the Molecular Mechanism of CD4+ T Cell Migration to the Brain." The project aims to investigate the molecular mechanisms of CD4+ T cell migration to the brain during...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $245,250 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. The grant will fund the development of a novel mouse model to study the immunological consequences of neonatal colonization with the commensal fungus Candida albicans. The research aims to characterize oral mucosal immune cell populations in...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $822,015 Project Grant titled "NOVEL STATISTICAL METHODS FOR CONFOUNDED AND INCOMPLETE NETWORK DATA" to the University of Pennsylvania. This grant, provided under the NIAID's Allergy and Infectious Diseases Research program (CFDA 93.855), will fund the development of new statistical methodologies to address challenges posed by missing data, confounding, and complex social network structures in studies of public...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Johns Hopkins University a 5-year, $1,546,730 Project Grant under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) to support the continuation and expansion of the Johns Hopkins HIV Implementation Science Hub (Hopkins Hub). The key objectives of this award are to: 1) enhance the technical rigor of implementation science research and build capacity among investigators focused on ending...
- This $838,320 Project Grant award was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855). The grant will fund research to investigate fungal pathogenicity determinants and their relationship to emerging cancer therapies that can lead to increased risk of invasive fungal infections. Specifically, the research aims to understand the mechanism by which inhibition of the Bruton's...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $248,088 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Johns Hopkins University on January 12, 2025. The research aims to examine the role of immunoglobulin E (IgE) and the sugar-binding protein galectin-3 in the activation of basophils, which are immune cells involved in allergic reactions. Specifically, the project will compare galectin-3-dependent basophil activation...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $147,486 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Johns Hopkins University. The purpose of this 20-month grant, with a period of performance from September 2025 to April 2027, is to identify metabolic targets that could reinvigorate exhausted T cells and enhance their function against viruses, bacteria, and tumors. The research aims to elucidate how chronic T cell...
The National Institute of Allergy and Infectious Diseases (NIAID), through the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), awarded a $197,640 Project Grant to The Johns Hopkins University to assess the impact of spatial and social determinants on the risk and outcomes of invasive fungal infections (IFIs). The 5-year project aims to: 1) Determine neighborhood-level contextual and socioeconomic predictors of IFIs, and 2) Examine the association between individual socioeconomic status factors and clinical outcomes of IFIs. This research will leverage national and hospital-system electronic health data to advance the understanding of spatial and social factors that influence IFI risk and outcomes, while also providing training for the early-career investigator, Dr. Lucy Li.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $197.6k | 7/30/25 |